Situation:
A large medical device company needed help with regulatory and clinical due diligence to effectively position itself for decisions on a target technology acquisition.
Solutions:
-
Based on Halloran's competitive intelligence in the therapeutic area, the market, and emerging technologies, the company identified a target technology for acquisition.
-
Halloran evaluated the target product, a potential fast follower technology, by conducting a detailed regulatory precedence research, an extensive patent review, and competitive research on similar products.
-
Based on this extensive research, Halloran provided the company's executive team with a clinical and regulatory strategy, focusing on risk assessment, to develop the product for global approval.
Value:
Halloran's deep technology review, regulatory diligence expertise, and expert risk identification helped the company develop a robust evaluation plan to support their positioning on acquisition plans.